Show simple item record

dc.contributor.authorDacosta Sánchez, Daniel 
dc.contributor.authorGonzález Ponce, Bella M.
dc.contributor.authorFernández Calderón, Fermín 
dc.contributor.authorSánchez García, Manuel 
dc.contributor.authorLozano Rojas, Óscar Martín 
dc.date.accessioned2022-07-06T11:31:42Z
dc.date.available2022-07-06T11:31:42Z
dc.date.issued2022
dc.identifier.citationDacosta‐Sánchez, D., González‐Ponce, B. M., Fernández‐Calderón, F., Sánchez‐García, M., & Lozano, O. M. (2022). Retention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real‐world data. In International Journal of Methods in Psychiatric Research. Wiley. https://doi.org/10.1002/mpr.1929es_ES
dc.identifier.issn1049-8931
dc.identifier.issn1557-0657 (electrónico)
dc.identifier.urihttp://hdl.handle.net/10272/21064
dc.description.abstractIntroduction Treatment retention and adherence are used as outcomes in numerous randomized clinical trials and observational studies conducted in the addiction field. Although usual criteria are 3/6 months of treatment retention or number of sessions attended, there is not a methodological support for conclusions using these criteria. This study analyzed the usefulness of retention and adherence to predict therapeutic success. Methods Retrospective observational study using real-world data from electronic health records of 11,907 patients in treatment diagnosed with cocaine, alcohol, cannabis and opiate use disorders or harmful use. Results Moderate effect size relations were found between the different type of clinical discharge and months in retention (η2 = 0.12) and proportion of attendance (η2 = 0.10). No relationship was found with the number of sessions attended. Using cut-off points (i.e., 3 or 6 months in treatment or attending 6 therapy sessions) worsens the ability to predict the type of discharge. Discussions/Conclusion Treatment retention and adherence are indicators moderately related to therapeutic success. Research using these indicators to assess the effectiveness of therapies should complement their results with other clinical indicators and quality of life measures.es_ES
dc.language.isoenges_ES
dc.publisherWiley Open Accesses_ES
dc.relation.isversionofPublisher’s version
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subject.otherAdherence to treatmentes_ES
dc.subject.otherOutcomeses_ES
dc.subject.otherRetention rateses_ES
dc.subject.otherSubstance abuse treatmentes_ES
dc.subject.otherTreatment monitoringes_ES
dc.titleRetention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real‐world dataes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.1002/mpr.1929
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.subject.unesco61 Psicologíaes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 España
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España

Copyright © 2008-2010. ARIAS MONTANO. Repositorio Institucional de la Universidad de Huelva
Contact Us | Send Feedback |